MUC1 and pulmonary fibrosis: Another study confirmed increased serum KL-6 levels in severe COVID-19 patients (n = 36), compared to moderate (n = 28) and mild (n = 49) patients, demonstrating that serum KL-6 levels positively correlated with an increased risk of developing lung fibrosis [136].